Member Info for Nolupus

Miggy,

Why are you saying , inconclusive/ no benefit hospital results ??

Omg

Should test 100 before going to 120 , imo

Let's wait and see

Totally agree, Shpunken

Let's hope we get there

Nice also to see some people back here now that the sp Is going up :-)

UP up up

SCoredagainsteps ,

Funding is always a major issue with IMM ...
Awaiting on news from Avion, INcanthera, UReka and FDA

We are due NEWS in the near future , imo

Beware of speeding tickets :-)

Nice to be back at my top up level though ...

Balanced66,

Difficult to give any opinion on other companies without doing a lot of research on them first ...
All one can do is research and keep an open mind whilst doing so ..
Wishing you the best with them

For those interested in the science

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7246018/?fbclid=IwAR3ERhr9bFSLU2nrfjtuJRjW9uvZxROggzeaW70eyOqHZUpN1oORxSzOwHE

It's about time :-)

Red is so depressing and makes ´bulls ´ agressive :-))

We will hopefully stay above the £1 level for a while ....

Notnow20 ,

If you think that it's stupid to analyse the various options , then so be it

I for one think that it's important to evaluate and debate the options , not for the reason of being ´right ´ or I told you so ´ but to be ready to react to this scenario or the other ... When one is prepared , one will be able to react accordingly ....

In my experience biotech investing is all about watching the angles ( and your back ) because as said before , the unexpected happens regularly .

Sharestring ,

Who is buying ?

Well , without any TR-1 it's difficult to say , don't you think ?
Many PI, including myself have bought more , but that does'nt explain the daily volumes ...
When one sees 300k + trades going through , it's hard to imagine that it's PI Who are buying .....

Notnow20 ,

I know it's ´popular ´ on this board to pest about me and my contrarien posts .
You amongst others have wanted me filtered or musseled since the beginning .

If you have learnt nothing from my posts then tough luck on you :-)

This is not a popularity contest but a place of debate where both sides of the coin should be exposed....
There are those like you who only want to see your own viewpoint reinforced and have the others shut up :-)

GHia,

I think we should stop focusing on Lansdowne as we are only seeing the tip of the iceberg ...
Without TR-1 we are only guessing and imo lot's of shares are now ´ under the radar ´ ....

We should be asking ourselves who are buying and not just who is selling , imo

Int

Ghia,

Without talking about ´ priviligied information ´ or insider trading which we know only happens in films :-)
The II has always got a better access to information circulating in the market, than any PI....
They have access to all financial records and data from many sources
They will always be one step ahead of any PI but

They don't have access to any un published clinical data so we are all on the same footing in that context

Whilst we are solely focusing on Synairgen they will be focusing on the general market as they will have their fingers in many pies .

Some are assuming that they continue to sell here , and that they are distressed sellers , some would also point out that they have supported SNG for many years and even more recently in the last placing . We are all disappointed that the SP is not going the way we had anticipated but it's just too easy to say it's the fault of ´ distressed II ´. Imo

IF one believes that they know more than Lansdowne who have invested millions in SNG over the years and therefore have done a hell of a lot of research into the company and it´s markets well they should maybe think again , imo

John117,

That is a very possible, and would be a great opportunity for SNG to do a rapid P3 in covid19
But as
Sharestring always says , COPD is the main focus for SNG so it's important imo for them to use the current limelight to progress quickly in COPD as well

SCoredagainsteps,

Off topic ....MPH , don't know them at all, sorry

My money is on TILS and SNG

TIlS doing very well and could do much more

SNG , losing money there for the moment but should be a good mover in the near future ....

Best of luck

Help, we can't even organize a beeping AGM .....

Pfff

Christoffer,

We had the case with IMM , where they Did a £10 million placement a month or so before their P3 readout ...

The further SNG can advance on the regulatory process independently the higher the stakes for pharma is also true ...
P3 trials are the most expensive of all trials so the ideal time to sign deals with pharma is after a succesful phase 2 ....

Let's wait and see